Common Blood Pressure Drug Shows Surprising Power Against Deadly Antibiotic-Resistant Superbug

Researchers reported that the blood pressure drug candesartan cilexetil damages MRSA cell membranes and reduces biofilm formation in lab tests.

The findings suggest a repurposing path that could speed development of cheaper treatments for antibiotic-resistant MRSA infections.

The study, published in Nature Communications, involved Eleftherios Mylonakis, Nagendran Tharmalingam, and Houston Methodist.